Evidence map›Paper›PMID 33407570›Full record

ArticleJournal of nanobiotechnology2021

Synergy of hypoxia relief and heat shock protein inhibition for phototherapy enhancement.

Gutian Zhang, Wenting Cheng, Lin Du, Chuanjun Xu, Jinlong Li

Open access · goldAbstract read
In one paragraph

Article in Journal of nanobiotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 93 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Gutian ZhangDepartment of Urology, Drum Tower Hospital, Medical School of Nanjing University, Nanjing, 210008, China. zhang.gutian@nju.edu.cn.
Wenting ChengDepartment of Laboratory Medicine, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, 210003, China.
Lin DuDepartment of Urology, Drum Tower Hospital, Medical School of Southeast University, Nanjing, 210008, China.
Chuanjun XuDepartment of Laboratory Medicine, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, 210003, China.
Jinlong LiDepartment of Laboratory Medicine, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, 210003, China. lijinlong1028@126.com.ORCID http://orcid.org/0000-0002-0425-8397
Nanjing University of Chinese Medicine · CNNanjing Drum Tower Hospital · CN

Funding

Medical Science and Technology Development Foundation, Nanjing Department of Health YKK19110National Natural Science Foundation of China 11774167National Natural Science Foundation of China 81703088
6 · The paper itself

Abstract

backgroundPhototherapy is a promising strategy for cancer therapy by reactive oxygen species (ROS) of photodynamic therapy (PDT) and hyperthermia of photothermal therapy (PTT). However, the therapeutic efficacy was restricted by tumor hypoxia and thermal resistance of increased expression of heat shock protein (Hsp). In this study, we developed albumin nanoparticles to combine hypoxia relief and heat shock protein inhibition to overcome these limitations for phototherapy enhancement.

resultsNear-infrared photosensitizer (IR780) and gambogic acid (GA, Hsp90 inhibitor) were encapsulated into albumin nanoparticles via hydrophobic interaction, which was further deposited MnO

conclusionThis study develops a facile approach to co-deliver IR780 and GA with self-assembled albumin nanoparticles, which could relive hypoxia and suppress Hsp for clinical application of cancer phototherapy.

Indexed as

AnimalsAntineoplastic AgentsCell SurvivalHeat-Shock ProteinsHSP90 Heat-Shock ProteinsHydrophobic and Hydrophilic InteractionsHypoxiaInfrared RaysMaleManganese CompoundsMiceMice, Inbred BALB CNanoparticlesOxidesPhotosensitizing AgentsPhototherapyAntineoplastic Agentsgambogic acidHeat-Shock ProteinsHSP90 Heat-Shock ProteinsManganese CompoundsOxidesPhotosensitizing AgentsXanthones

Identifiers

PMID33407570
PMCPMC7789325
OpenAlexW3120574651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.